Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial.

McInnes IB, Ferraccioli G, D'Agostino MA, Le Bars M, Banerjee S, Ahmad HA, Elbez Y, Mease PJ

Open source

DOI
10.1136/rmdopen-2019-000934
Published
2019
Container
RMD open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2019-000934,
  title = {Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial.},
  author = {McInnes IB and Ferraccioli G and D'Agostino MA and Le Bars M and Banerjee S and Ahmad HA and Elbez Y and Mease PJ},
  year = {2019},
  journal = {RMD open},
  doi = {10.1136/rmdopen-2019-000934},
  url = {https://doi.org/10.1136/rmdopen-2019-000934}
}

RIS

TY  - JOUR
TI  - Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial.
AU  - McInnes IB
AU  - Ferraccioli G
AU  - D'Agostino MA
AU  - Le Bars M
AU  - Banerjee S
AU  - Ahmad HA
AU  - Elbez Y
AU  - Mease PJ
PY  - 2019
JO  - RMD open
DO  - 10.1136/rmdopen-2019-000934
UR  - https://doi.org/10.1136/rmdopen-2019-000934
ER  - 

APA

IB, M., G, F., MA, D., M, L. B., S, B., HA, A., Y, E., & PJ, M. (2019). Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial.. RMD open. https://doi.org/10.1136/rmdopen-2019-000934

Source records